AG
SWAV

Artal Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Artal Group’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-150,000
Closed -$5.02M – 121
2019
Q1 		$5.02M Buy
+150,000
New +$4.98M 0.21% 75

Other funds holding SWAV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Artal Group's SWAV Position: Q2 2019 in Review

Artal Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2019, closing a stake of 150,000 shares — an estimated $5.02M sold.

Artal Group first reported a position in SWAV in Q1 2019 and held it in 1 quarter. The position peaked at $5.02M in Q1 2019. 90 funds tracked by Wall St. Rank hold SWAV as of Q2 2019.

  • Artal Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Artal Group sold 150,000 Shockwave Medical, Inc. Common Stock shares in Q2 2019, an estimated $5.02M.
  • Artal Group first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • Artal Group's Shockwave Medical, Inc. Common Stock position peaked at $5.02M in Q1 2019.
  • 90 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2019.

Based on Artal Group's 13F filing for Q2 2019, filed 9 Aug 2019.